TickerFacts.

ResMed Inc (RMD): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2018-06-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.20B
Year ended 2026-06-30
+5.6%
3-year compound annual growth
+10.2%
5-year compound annual growth
2009-06-30: $366.93M2010-06-30: $436.87M2011-06-30: $501.82M2012-06-30: $547.78M2013-06-30: $573.80M2014-06-30: $565.19M2015-06-30: $667.52M2016-06-30: $772.22M2017-06-30: $864.99M2018-06-30: $1.01B2019-06-30: $1.11B2020-06-30: $1.24B2021-06-30: $1.36B2022-06-30: $1.55B2023-06-30: $1.87B2024-06-30: $2.03B2025-06-30: $2.09B2026-06-30: $2.20B$2.20B
2009-06-30 Cost of Revenue (USD) 2026-06-30
Period endedCost of RevenueChange YoYSource filing
2026-06-30$2.20B+5.3%2026-08-13, From 2025-07-01
2025-06-30$2.09B+3.0%2026-08-13, From 2024-07-01
2024-06-30$2.03B+8.7%2026-08-13, From 2023-07-01
2023-06-30$1.87B+20.2%2025-08-08, From 2022-07-01
2022-06-30$1.55B+14.4%2024-08-09, From 2021-07-01
2021-06-30$1.36B+9.6%2023-08-11, From 2020-07-01
2020-06-30$1.24B+11.4%2022-08-12, From 2019-07-01
2019-06-30$1.11B+10.7%2021-08-17, From 2018-07-01
2018-06-30$1.01Bn/c2020-08-13, From 2017-07-01
2017-06-30$864.99M+12.0%2019-08-08, From 2016-07-01
2016-06-30$772.22M+15.7%2018-08-17, From 2015-07-01
2015-06-30$667.52M+18.1%2017-08-04, From 2014-07-01
2014-06-30$565.19M-1.5%2016-08-05, From 2013-07-01
2013-06-30$573.80M+4.8%2015-08-07, From 2012-07-01
2012-06-30$547.78M+9.2%2014-08-08, From 2011-07-01
2011-06-30$501.82M+14.9%2013-08-13, From 2010-07-01
2010-06-30$436.87M+19.1%2012-08-14, From 2009-07-01
2009-06-30$366.93Mn/a2011-08-17, From 2008-07-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
ResMed Inc (RMD)2026-06-30$2.20B+5.3%
Dexcom Inc (DXCM)2025-12-31$1.86B+16.6%
MiniMed Group, Inc. (MMED)2026-04-24$1.42B+19.8%
West Pharmaceutical Services Inc (WST)2025-12-31$1.97B+4.0%
Globus Medical Inc (GMED)2025-12-31$957.80M-7.5%
Baxter International Inc (BAX)2025-12-31$7.87B+18.2%
Insulet Corp (PODD)2025-12-31$768.20M+22.7%
ICU Medical Inc (ICUI)2025-12-31$1.41B-9.5%
Teleflex Inc (TFX)2025-12-31$871.96M+31.7%

Compare RMD, DXCM, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗